Skip to content

Blood Flow Restriction After Meniscus Repair

Outcomes of Blood Flow Restriction Training in Post-operative Rehabilitation After Meniscus Repair Surgery

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04436523
Enrollment
15
Registered
2020-06-18
Start date
2020-10-20
Completion date
2023-06-08
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy, Muscular, Meniscus Disorder, Meniscus Lesion, Meniscus Tear, Tibial, Meniscus, Torn Tibial

Keywords

blood flow restriction, rehabilitation, meniscus repair

Brief summary

The purpose of this study is to evaluate post-operative outcomes after meniscus surgery in participants undergoing blood flow restriction training as a rehabilitative adjunct compared to those with standard rehabilitation.

Detailed description

The investigators will conduct a double-blinded, single-institution, randomized controlled trial to compare patients undergoing arthroscopic meniscus repair with post-operative rehabilitation protocol as (1) a standard-of-care rehabilitative protocol with a non-occlusive blood pressure cuff (inflated to 20-30 mm Hg) applied to the operative extremity versus (2) blood flow restriction training with cuff occlusion applied to the operative extremity. Patients will be enrolled prospectively and pre-operatively at their initial clinic visit after meniscus injury. Rehabilitative exercises would be advanced per the physical therapists' discretion with similar exercises for patients in both groups for direct comparison. These exercises are part of an already-established post-operative protocol that is in place, with the only difference being the addition of the blood flow restriction protocol in the intervention group. All patients would undergo their supervised post-operative rehabilitation at our institution.

Interventions

DEVICEBlood flow restriction (Delfi Personalized Tourniquet System)

The Delfi Personalized Tourniquet System will be utilized to apply the blood flow restriction protocol.

OTHERStandard rehabilitation

Post-operative physical therapy as guided by a standardized protocol for patients undergoing meniscus repair.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Participants who undergo surgery for arthroscopic meniscus repair

Exclusion criteria

* Participants undergoing surgery for concomitant ligamentous surgeries * Patients with Diabetes Mellitus, vascular disease, or infections of the involved extremity

Design outcomes

Primary

MeasureTime frameDescription
Knee Extension Force at Week 1Week 1 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 2Week 2 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 3Week 3 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 4Week 4 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 5Week 5 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 6Week 6 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 7Week 7 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 8Week 8 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 9Week 9 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 10Week 10 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 11Week 11 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Knee Extension Force at Week 12Week 12 (Evaluated weekly at physical therapy visits from 0-12 weeks)Peak knee extension force (lbs) evaluated with a hand-held dynamometer
Thigh Circumference at Week 1Week 1 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 2Week 2 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 3Week 3 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 4Week 4 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 5Week 5 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 6Week 6 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 7Week 7 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 8Week 8 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 9Week 9 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 10Week 10 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 11Week 11 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh
Thigh Circumference at Week 12Week 12 (Evaluated weekly at physical therapy visits from 0-12 weeks)Measurement of thigh circumference (centimeters) will be performed utilizing tape measures at specified distances along the thigh

Secondary

MeasureTime frameDescription
International Knee Documentation Committee (IKDC) Score at Week 66 weeks (measured at 6 weeks, 3 months, and 6 months post-operatively)Patient-reported outcome measure (numerical score) from survey. Min: 0 = lowest level of function/highest level of symptoms. Max: 100 = highest level of function/lowest level of symptoms
International Knee Documentation Committee (IKDC) Score at Week 123 months (measured at 6 weeks, 3 months, and 6 months post-operatively)Patient-reported outcome measure (numerical score) from survey. Min: 0 = lowest level of function/highest level of symptoms. Max: 100 = highest level of function/lowest level of symptoms
International Knee Documentation Committee (IKDC) Score at Week 246 months (measured at 6 weeks, 3 months, and 6 months post-operatively)Patient-reported outcome measure (numerical score) from survey. Min: 0 = lowest level of function/highest level of symptoms. Max: 100 = highest level of function/lowest level of symptoms
Y-balance Testing at Week 123 months (performed at 3 months and 6 months post-operatively)Functional outcome measure (numerical score). The lower quarter Y-balance test evaluates dynamic stability and functional symmetry. The subject stands on a single leg and reaches in three directions (anterior, posteromedial, posterolateral) and a composite score is calculated as a percentage: (sum of reach distances in centimeters in each direction) / (3\*limb length) \* 100.
Y-balance Testing at Week 246 months (performed at 3 months and 6 months post-operatively)Functional outcome measure (numerical score). The lower quarter Y-balance test evaluates dynamic stability and functional symmetry. The subject stands on a single leg and reaches in three directions (anterior, posteromedial, posterolateral) and a composite score is calculated as a percentage: (sum of reach distances in centimeters in each direction) / (3\*limb length) \* 100.
3-hop Test at Week 123 months (performed at 3 months and 6 months post-operatively)Functional outcome measure (numerical score). The 3-hop test assesses dynamic stability and limb control. The subject hops three times consecutively forward in a same line and at the final landing, pauses in position while a measurement is made from the starting line to the toe at the end of the final hop in centimeters. The test is compared to the contralateral, uninjured limb, and scoring is reported as a percentage of the uninjured limb.
3-hop Test at Week 246 months (performed at 3 months and 6 months post-operatively)Functional outcome measure (numerical score). The 3-hop test assesses dynamic stability and limb control. The subject hops three times consecutively forward in a same line and at the final landing, pauses in position while a measurement is made from the starting line to the toe at the end of the final hop in meters.
Single Leg Squat Testing at Week 123 months (performed at 3 months and 6 months post-operatively)Functional outcome measure (numerical score). Single leg squat testing evaluates core stability and ability to perform functional movement safely. Subjects will be asked to perform a single leg squat and will be evaluated on 5 criteria, with one point for clinician-rated good performance in each (A) maintenance in balance, depth, speed (B) trunk posture (C) pelvic rotation \& tilt (D) Hip adduction or femoral internal rotation (E) knee joint apparent valgus. Min: 0 = poor balance and motor control; Max: 5 = good balance and motor control
Single Leg Squat Testing at Week 246 months (performed at 3 months and 6 months post-operatively)Functional outcome measure (numerical score). Single leg squat testing evaluates core stability and ability to perform functional movement safely. Subjects will be asked to perform a single leg squat and will be evaluated on 5 criteria, with one point for clinician-rated good performance in each (A) maintenance in balance, depth, speed (B) trunk posture (C) pelvic rotation \& tilt (D) Hip adduction or femoral internal rotation (E) knee joint apparent valgus. Min: 0 = poor balance and motor control; Max: 5 = good balance and motor control

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSachin Allahabadi, MD

University of California, San Francisco

Baseline characteristics

Characteristic
Age, Continuous35.4 years
STANDARD_DEVIATION 12.6
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 70 / 8
other
Total, other adverse events
0 / 70 / 8
serious
Total, serious adverse events
0 / 70 / 8

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026